Furthermore, accumulating evidence indicates that CHIP is involved in metabolic pathways including cardiac dysfunction, lung inflammation, liver injury, and NASH [32,33,34,35]. This evidence concerns the gene STUB1 and metabolic dysfunction-associated steatohepatitis.